The Issuance Flood: SK hynix's $28B Nasdaq Debut Meets SpaceX's Lockup Gauntlet
A record $251B first-half issuance pace runs head-on into a wall of insider unlocks and secondary supply — the second half turns from a demand story to an absorption test.
U.S. equity capital markets just posted the biggest first half in history. Through late June 2026, U.S. issuers raised $251 billion in IPOs — surpassing the prior midyear record set during the 2021 listing boom — with SpaceX’s roughly $86 billion offering and Alphabet’s $85 billion AI-funding raise doing the heavy lifting.{{cite:f2b1bcc88025}} The pipeline shows no sign of slowing: 192 IPOs have priced on U.S. exchanges year-to-date as of July 6, a 9.1% increase over the same point in 2025.{{cite:eecb41e1018b}}
But the first half was fundamentally a demand story. The second half is shaping up to be a supply test. SK hynix’s $28 billion Nasdaq listing — the second-largest share sale on record — prices this week into a market that must also absorb staggered SpaceX insider lockup expirations, a wave of Hong Kong AI-stock unlocks, and a steady drumbeat of secondary offerings from capital-hungry issuers like Rivian. The question is no longer whether the market wants new paper. It is whether the market can digest it.
SK hynix: The $28B AI-Memory Listing
The deal of the week — and arguably the deal of the year outside SpaceX — is SK hynix’s Nasdaq ADS offering. The Icheon-based memory chipmaker set terms on July 7 for a $28.1 billion raise: 177.9 million American depositary shares priced at $158.14, the as-converted close of its KRX KOSPI-listed shares on July 3.{{cite:19d2511cc3de}} At that price, SK hynix commands a market capitalization of roughly $1.2 trillion.{{cite:19d2511cc3de}}
Cornerstone investors Baillie Gifford, Coatue Management, and Situational Awareness Partners have indicated on $7 billion of the deal — about 25% — providing a floor of committed demand.{{cite:19d2511cc3de}} The offering drew roughly $196 billion in total demand, making it oversubscribed about seven times.{{cite:82806e5bb676}} BofA Securities, Citi, Goldman Sachs, and J.P. Morgan lead a syndicate of fourteen bookrunners. Trading is expected to begin Friday, July 10, under the ticker SKHY.{{cite:19d2511cc3de}}
The strategic logic is straightforward: SK hynix is the world’s leading supplier of high-bandwidth memory (HBM), the specialized stacked DRAM that sits alongside Nvidia’s GPUs in every major AI accelerator.{{cite:82806e5bb676}} The company booked $84.9 billion in revenue for the twelve months ended March 31, 2026, and ranked first or second globally in DRAM, HBM, and NAND flash by revenue in Q1 2026.{{cite:19d2511cc3de}} With HBM supply constrained and AI infrastructure spending still accelerating, U.S. investors are getting their first direct access to the dominant HBM supplier — at a price that Renaissance Capital characterizes as essentially fair, priced at the Korean market equivalent rather than a U.S. premium.{{cite:82806e5bb676}}
The risk is the dilution overhang on the KOSPI. SK hynix’s Seoul-listed shares slid 6.7% during bookbuilding on dilution concerns,{{cite:82806e5bb676}} and the ADS structure means the U.S. float represents only a fraction of the total share count. The deal is large enough to move the semiconductor sector’s liquidity profile on its own — $28 billion of new stock entering the market in a single pricing event is not marginal.
SpaceX: The Lockup Clock Is Running
If SK hynix is about new supply entering the market, SpaceX is about existing supply becoming tradable. Space Exploration Technologies (SPCX) joined the Nasdaq-100 Index on July 7, 2026, triggering roughly $6 billion in automatic passive-fund buying — about 6% of the stock’s public float.{{cite:cef469d1df21}} Nasdaq’s weighting was adjusted to reflect SpaceX’s low float (only about 5% of shares were sold in the IPO), capping its index weight at approximately 0.75%.{{cite:cef469d1df21}}
But the mechanical demand from index funds is a one-time event. The structural supply overhang is staggered across the next twelve months, and it dwarfs the current float:
| Date | Shares Unlocking | Cumulative Float |
|---|---|---|
| June 12, 2026 | ~5% (IPO float) | 5% |
| August 11, 2026 | ~20% | ~25% |
| October 25, 2026 | ~35% | ~60% |
| November 9, 2026 | ~28% | ~88% |
| June 13, 2027 | ~12% | 100% |
Source: MarketWise analysis of SpaceX IPO lockup structure.{{cite:cef469d1df21}}
The August 11 unlock alone quadruples the tradable float. By mid-November, 88% of all SpaceX shares will be eligible for sale. Whether insiders actually sell depends on conviction and price — SpaceX has already fallen from a peak above $225 to roughly $150, a decline of about one-third — but the structural possibility is enormous.{{cite:cef469d1df21}} Independent valuations underscore the gap: Morningstar pegs fair value at $780 billion (implying roughly 61% downside from recent levels), NYU professor Aswath Damodaran values the company at $1.25–1.35 trillion (33–38% downside), and Danish pension fund AkademikerPension has blacklisted the stock over what it calls “catastrophic governance.”{{cite:cef469d1df21}}
My read on this is probabilistic rather than binary. The August unlock releasing 20% of shares into a market where only 5% currently trades is a genuine liquidity event — but not necessarily a crash trigger. SpaceX trades tens of millions of shares daily, and index-fund buying has established a price floor around current levels. The greater risk sits in the October–November window, when 63% of the company unlocks in a two-week span. That is where the absorption test becomes acute. If the stock is still trading at a $2 trillion valuation by then, the incentive for insiders to monetize is considerable.
Hong Kong’s $11.5B Lockup Wave — and the Counterintuitive Outcome
The Hong Kong market is running its own lockup experiment in real time. Six-month lock-up periods for Chinese AI leaders Zhipu AI (02513.HK) and MiniMax expired on July 8 and 9, respectively, releasing a combined HK$90 billion (US$11.5 billion) in previously restricted shares.{{cite:be86e81a00a3}}
The conventional playbook says lockup expirations trigger selling pressure. This time, the data broke the pattern. Zhipu’s stock surged 15–19% after the lockup expired, as nearly 70% of cornerstone investors pledged to hold rather than sell.{{cite:1faa0fdf85ab}} MiniMax shares were more muted, losing 3.3% on the expiry day after a similar drop the prior session.{{cite:be86e81a00a3}}
This is a useful base-rate correction for anyone mapping the SpaceX lockup timeline. The Hong Kong experience suggests that when a company’s long-term thesis remains intact, cornerstone holders can absorb the unlocked supply. But the conditions are specific: Zhipu’s investors explicitly committed to hold, the unlocked tranche was 25.68 million shares out of 446 million total (about 6%), and the stock had already corrected sharply before expiry.{{cite:be86e81a00a3}} SpaceX’s August unlock will release four times the current float — a structurally different ratio.
The Secondary Market: Rivian’s $1.32B Raise and the Buyback Counterweight
New issuance is only half the supply equation. Rivian Automotive (RIVN) priced an underwritten offering of 75 million Class A shares at $15.50 per share on July 8, raising $1.32 billion — with a greenshoe of 11.25 million shares potentially bringing the total to $1.5 billion.{{cite:2c7b6d9bcfef}} The capital is earmarked for the equity contribution required under Rivian’s Department of Energy loan facility, tied to the R2 vehicle program launch.{{cite:2c7b6d9bcfef}} The stock slipped on the dilution, a reminder that even purposeful, use-of-proceeds-clarified secondaries carry a price.
On the other side of the ledger, buybacks are withdrawing capital from the market at a record clip. JPMorgan Chase (JPM) authorized a $50 billion common share repurchase program in late June after clearing the Federal Reserve’s annual stress test — all 32 of the nation’s largest banks survived the hypothetical downturn.{{cite:a9e68e76d185}} The bank also raised its quarterly dividend 10% to $1.65 per share.{{cite:a9e68e76d185}} Banco Santander is executing its own multi-billion-euro buyback program, reporting transactions for the week of July 2–8 in a Form 6-K filing.{{cite:66c568e7b33a}}
Smaller deals round out the week’s secondary calendar: Rackspace Technology (RXT) filed a $250 million at-the-market equity distribution program through Goldman Sachs{{cite:66c568e7b33a}}; MDA Space launched a treasury offering of common shares in Canada and the U.S.{{cite:66c568e7b33a}}; and the IPO pipeline includes Csquare ($1.25 billion, Morgan Stanley/TD Securities) and Standard Nuclear ($356 million, BofA/Goldman) pricing in the coming weeks.{{cite:8a5b11c564e5}}
The IPO Pipeline Behind the Headlines
Beyond the mega-deals, the U.S. listing calendar is populated by a diverse mix:
| Company | Ticker | Deal Size | Lead Underwriters | Status |
|---|---|---|---|---|
| SK hynix | SKHY | $28.1B | BofA, Citi, Goldman, JPM | Pricing this week |
| Csquare | CSQR | $1.25B | Morgan Stanley, TD Securities | Upcoming |
| Standard Nuclear | STDN | $356M | BofA, Goldman | Upcoming |
| Columbus Circle III | CCCTU | $200M | Cohen & Co., Clear Street | Priced 7/9 |
| Mercator Acquisition | MRCOU | $150M | Clear Street | Priced |
| Tarsier Pharma | TARX | $45M | Konik Capital | Upcoming |
Source: Renaissance Capital IPO Calendar.{{cite:8a5b11c564e5}}
The SPAC count (Columbus Circle III, Mercator Acquisition) reflects the steady but unspectacular return of blank-check vehicles — neither a boom nor a revival, just background issuance. The more notable signal is Csquare’s $1.25 billion deal with a bulge-bracket syndicate, suggesting that mid-cap technology issuers are finding a receptive window.
What to Watch Next
-
SK hynix first-day performance (Friday, July 10): The seven-times oversubscription book is a strong demand signal, but the real test is the aftermarket. If SKHY trades below the $158.14 offer price, it signals that even cornerstoned mega-deals face absorption limits. A premium open sets a constructive tone for the H2 pipeline.
-
SpaceX August 11 unlock: This is the first true liquidity event for SPCX — 20% of shares becoming tradable, quadrupling the float. Watch for insider filing activity (Form 4 sales) in the days following and the stock’s ability to hold above the $150 level where it has stabilized.
-
Rivian’s use of proceeds: The $1.32B raise funds DOE loan equity requirements for the R2 program. If Rivian’s Q2 earnings (due in coming weeks) show delivery momentum continuing, the dilution narrative fades. If deliveries stall, the raise looks like capital survival rather than growth investment.
-
JPMorgan buyback execution pace: The $50B authorization is a ceiling, not a floor. The speed at which JPM repurchases shares sets the tone for bank-sector capital returns and provides a liquidity counterweight to the issuance wave. Q2 earnings, expected mid-July, will include updated repurchase guidance.
-
Hong Kong follow-on placements: SCMP reported that several recently unlocked AI companies are eyeing secondary share placements alongside the lockup expirations.{{cite:be86e81a00a3}} If placements accelerate, Hong Kong’s $11.5B lockup wave could compound into a larger liquidity drain.
The base-rate case here is constructive but not unconditionally so. The first half proved that institutional demand can absorb $251 billion in issuance when the deals are high-quality and the macro backdrop is stable. The second half raises the degree of difficulty: the supply is increasingly insider-driven rather than company-driven, the valuations on the largest unlocked names are contested, and the concentration of unlocks in a narrow October–November window creates a specific absorption bottleneck. I’d put the odds of a smooth digestion at roughly 60/40 — the market’s depth has expanded materially since 2021, but the sheer concentration of supply in SpaceX alone is without modern precedent. The 40% scenario is not a crash; it is a messy, volatile repricing as the market discovers the clearing price for a much larger float.